Clincosm LogoSign in Get a demo

pachyonychia congenita

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita Trial in London (IMP Application KM-001, Physical Examination,

Recruiting
  • Punctate Palmoplantar Keratoderma Type 1
  • Pachyonychia Congenita
  • IMP Application KM-001
  • +14 more
  • London, Whitechapel Rd, United Kingdom
    Royal London Hospital-Clinical Research Facility-11D (11th Floor
Jul 23, 2023

Pachyonychia Congenita Trial in New Brighton (PTX-022)

Recruiting
  • Pachyonychia Congenita
  • New Brighton, Minnesota
    Minnesota Clinical Study Center
Dec 1, 2022

Pachyonychia Congenita Trial in United Kingdom, United States (QTORIN 3.9% rapamycin anhydrous gel, Vehicle)

Recruiting
  • Pachyonychia Congenita
  • QTORIN 3.9% rapamycin anhydrous gel
  • Vehicle
  • Palo Alto, California
  • +7 more
Feb 25, 2022

Pachyonychia Congenita Trial in United States (PTX-022)

Active, not recruiting
  • Pachyonychia Congenita
  • Phoenix, Arizona
  • +3 more
Dec 2, 2021

Pachyonychia Congenita Trial in Salt Lake City

Recruiting
  • Pachyonychia Congenita
    • Salt Lake City, Utah
      Pachyonychia Congenita Project
    Nov 19, 2018

    Epidermolysis Bullosa Simplex, Pachyonychia Congenita Trial in Baltimore (Jojoba oil with broccoli sprout extract, Jojoba oil

    Completed
    • Epidermolysis Bullosa Simplex
    • Pachyonychia Congenita
    • Jojoba oil with broccoli sprout extract
    • Jojoba oil (placebo)
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Dec 4, 2017

    Pachyonychia Congenita Trial in Stanford (1% sirolimus cream (TD201 1%))

    Completed
    Has Results
    • Pachyonychia Congenita
    • 1% sirolimus cream (TD201 1%)
    • Stanford, California
      Stanford University
    Oct 5, 2016

    Pachyonychia Congenita Trial (Simvastatine)

    Unknown status
    • Pachyonychia Congenita
    • (no location specified)
    Jun 23, 2011

    Pachyonychia Congenita Trial in Salt Lake City (TD101, Normal saline ())

    Completed
    • Pachyonychia Congenita
    • TD101
    • Normal saline (placebo)
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Nov 18, 2008